|
|
 |
|
Total Number of Holdings (excluding cash): 50
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$93,181.69 |
2.87% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$90,463.89 |
2.79% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$84,619.81 |
2.61% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$84,283.76 |
2.60% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$82,361.74 |
2.54% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$82,208.37 |
2.54% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$82,116.36 |
2.53% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$82,019.88 |
2.53% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$79,801.92 |
2.46% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$79,397.01 |
2.45% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$78,701.76 |
2.43% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$77,967.04 |
2.40% |
| Waters Corporation |
WAT |
941848103 |
184 |
$76,256.96 |
2.35% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$74,645.40 |
2.30% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$74,121.70 |
2.29% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$72,495.96 |
2.24% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$72,768.55 |
2.24% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$72,269.29 |
2.23% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$70,251.86 |
2.17% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$69,809.64 |
2.15% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$68,788.59 |
2.12% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$68,284.44 |
2.11% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$66,950.70 |
2.06% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$66,928.00 |
2.06% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$63,492.16 |
1.96% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$63,451.92 |
1.96% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$63,101.25 |
1.95% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$63,060.12 |
1.94% |
| Steris Plc |
STE |
G8473T100 |
265 |
$62,656.60 |
1.93% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$61,610.64 |
1.90% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$61,745.85 |
1.90% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$61,040.22 |
1.88% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$60,477.12 |
1.86% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$59,645.37 |
1.84% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$57,737.86 |
1.78% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$57,522.66 |
1.77% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$56,761.68 |
1.75% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$55,400.36 |
1.71% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$54,267.40 |
1.67% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$54,089.92 |
1.67% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$51,266.10 |
1.58% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$49,191.95 |
1.52% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$48,339.20 |
1.49% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$47,992.65 |
1.48% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$47,616.30 |
1.47% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$47,807.60 |
1.47% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$46,176.52 |
1.42% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$42,915.00 |
1.32% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$40,590.58 |
1.25% |
| US Dollar |
$USD |
|
13,864 |
$13,864.22 |
0.43% |
| Yuan Renminbi |
$CNY |
|
1,824 |
$271.41 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|